Artwork

Content provided by Certara Evidence & Access and Certara Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Certara Evidence & Access and Certara Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

(3) The Part B IPI Model

26:06
 
Share
 

Manage episode 223345041 series 2415349
Content provided by Certara Evidence & Access and Certara Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Certara Evidence & Access and Certara Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing. Experts on call Ulrich Neumann, Sr. Director, US Access ulrich.neumann@certara.com Additional notes: - We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449. DOI: 10.1257/jel.20161327 --- Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
  continue reading

4 episodes

Artwork
iconShare
 
Manage episode 223345041 series 2415349
Content provided by Certara Evidence & Access and Certara Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Certara Evidence & Access and Certara Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing. Experts on call Ulrich Neumann, Sr. Director, US Access ulrich.neumann@certara.com Additional notes: - We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449. DOI: 10.1257/jel.20161327 --- Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
  continue reading

4 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide